Study to Evaluate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of JTT-662 in Subjects With Type 2 Diabetes
Clinical trial NCT04465877 · COMPLETED
Trial details
- NCT number
- NCT04465877
- Sponsor
- Akros Pharma Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-15
- Primary completion
- 2021-02-17
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.